Protara Therapeutics, Inc. (TARA) › Shares OutstandingProtara Therapeutics, Inc. (TARA) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 239.9K2014: 16.45M2015: 16.50M2016: 16.60M2017: 17.67M2018: 481.1K2019: 2.63M2020: 11.21M2021: 11.24M2022: 11.27M2023: 11.36M2024: 35.04M2025: 53.59M53.59M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202553.59M+52.9%202435.04M+208.4%202311.36M+0.9%202211.27M+0.3%202111.24M+0.2%202011.21M+326.7%20192.63M+446.2%2018481.1K-97.3%201717.67M+6.5%201616.60M+0.6%201516.50M+0.3%201416.45M+6756.2%2013239.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share